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ABSTRACT 
Aim To determine antimicrobial activity of honey against clinical 
bacterial strains and their respective reference strains. 
Methods Twelve samples of Croatian honey from various bota-
nical origin were evaluated for their antimicrobial activity against 
four clinical antibiotic resistant pathogens and their respective re-
ference strains: Staphylococcus aureus, Acinetobacter baumannii, 
Pseudomonas aeruginosa and Escherichia coli. Antibacterial 
susceptibility was checked out by using broth microdilution met-
hod and interpreted according to the European Committee for An-
timicrobial Susceptibility Testing (EUCAST) recommendations. 
Results Significant differences in the antibacterial activity of te-
sted honey samples were noticed. Fir honeydew honey and Mint 
honey showed the best antibacterial potential, while the Locust 
tree honey, Rapeseed honey and Spring pasture honey expressed 
the weakest antimicrobial activity. 
Conclusion Croatian honey, prominently honeydew honey, has 
the potential to become an important additive to therapeutic tech-
niques available to a medical practitioner against resistant patho-
gens, but the exact mechanisms of its activity should be investi-
gated further.
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INTRODUCTION
For a thousand of years honey has been used for 
the treatment of wounds. However, broader appli-
cation in medicine is limited due to the lack of sci-
entific support. Nowadays, the bacterial resistance 
to antimicrobial agents and numerous kinds of an-
tibiotics, including the major resort drugs, is incre-
asing worldwide (1-3). Therefore, alternative an-
timicrobial strategies are urgently needed and the 
potent activity of honey against antibiotic resistant 
bacteria resulted in renewed interest for its appli-
cation (4-6). An additional advantage of topical 
use of honey as an antimicrobial agent is the fact 
that bacterial resistance to honey has not yet been 
described. The reason lies in the fact that honey 
inhibits bacteria using several mechanisms at the 
same time, which prevents them from developing 
resistance (7,8). Antibacterial activity of different 
honey is mainly due to hydrogen peroxide produc-
tion, as well as the presence of various phytoche-
micals. In addition, honey is hygroscopic, which 
means that it can dehydrate bacteria, and its high 
sugar content and low pH level can also prevent 
the microbes from growth (7-9). In addition, un-
known floral or bee components contribute to an-
tibacterial activity (8-10).  There are many types 
of honey that originate from different geographic 
areas and are made from different floral sources. 
Studies have shown that honey with these marked 
differences can have different antimicrobial acti-
vities and mechanisms of action (7,11). In addi-
tion, the antibacterial potency of diverse, locally 
produced honey is not possible to predict. Some 
studies showed that even honey collected from a 
single location can have significant batch-to-batch 
variation in antibacterial activity (10). The unpre-
dictable antibacterial activity of such unstandardi-
sed honey preparations hampers its introduction as 
an antimicrobial agent (6). 
Croatia has a large floral biodiversity and 
honey produced from these plants has been sold 
commercially in Croatia and in EU countries. 
However, data on antibacterial activity of diffe-
rent types of honey produced in Croatia are very 
scarce. Therefore, the aim of this study was to 
investigate the antibacterial activity of dome-
stic honey from different floral origin, as well as 
honeydew honey, a bee product obtained from 
excretion of plant sucking insects, on selected 
pathogen bacteria.
MATERIAL AND METHODS
Honey samples, bacteria and study design
Twelve honey samples (HS) from different plant 
origin were obtained during the year 2014 (Table 
1) and its antimicrobial activity was tested using 
bacterial strains originated from the collection of 
the Department of Microbiology and Parasito-
logy, Faculty of Medicine, University of Rijeka, 
Croatia. Honey samples originated from different 
geographic areas in the Western part of Croatia: 
Sage honey, Maple honeydew, Fir honeydew, 
Chestnut honey, 
Locust tree honey, Lime tree honey, Indigo bush 
honey, Rapeseed honey, Maple honey, Mint honey, 
Spring pasture honey and Autumn pasture honey. 
Honey samples Number of samples Type
Sage honey (Salvia officinalis L.) 1, 2 monofloral
Maple honeydew (Acer spp.) 1 honeydew
Fir honeydew (Abies alba Mill) 1, 2 honeydew
Chestnut honey (Castanea sativa Mill) 1 monofloral
Locust tree honey (Robinia pseudoacacia L.) 1 monofloral
Lime treehoney (Tilia spp.) 1 monofloral
Indigo bush honey (Amorfa fruticosa L.) 1 monofloral
Rapeseed honey (Brassica napus L.) 1 monofloral
Maple honey (Acer spp.) 1 monofloral
Mint honey (Mentha spp.) 1 monofloral
Spring pasture honey 1 polifloral
Autumn pasture honey 1 polifloral
Table 1. The origin of tested honey samples
Methods
No mechanical treatment or heat was used in sam-
ple preparations. The HS was stored at +4 °C in 
hermetically closed glass bottles until used. The 
sediments of the HS were analysed according to 
the method recommended by the International 
Commission for Bee Botany of International Uni-
on of Biological Sciences (12). The antibacterial 
activity of tested HS was investigated using the 
reference bacterial strains: Staphylococcus aure-
us ATCC 25923, Acinetobacter baumannii ATCC 
BAA–1605 (multidrug resistant), A. baumannii 
ATCC 19606 (drug sensitive), Pseudomonas 
aeruginosa ATCC 27853, and Escherichia coli 
ATCC 25922 as well as several clinical bacteri-
al isolates such as methicillin-resistant S. aureus 
(MRSA), P. aeruginosa (multidrug resistant) and 
extended spectrum beta-lactamase (ESBL) - po-
sitive E. coli. The bacteria were stored at -80 °C 
in glycerol broth (10% glycerol) (Biolife, Italy). 
For the experiments, bacteria were thawed at room 
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temperature, resuspended in Mueller-Hinton broth 
(MHB) (Difco, MD, USA) for 24 h at 37 °C and 
120 rpm (Unimax 1010, Heidolph, Germany). 
Minimal inhibitory concentrations (MICs) and 
minimal bactericidal concentrations (MBCs) 
were determined using a broth dilution met-
hod, and interpreted according to the European 
Committee for Antimicrobial Susceptibility Te-
sting (EUCAST) recommendations (13). Initial 
inoculum for all experiments was approximately 
1.0×106 CFU/mL as determined by the turbidity 
of the bacterial suspension and confirmed re-
trospectively by plating the inoculum on Mu-
eller-Hinton agar (MHA) (Difco, MD, USA) for 
24 h at 37 °C. Further, twofold serial dilutions 
in MHB were prepared from a stock solution of 
each honey sample to get final concentrations 
ranging from 0.025 to 0.8 g/mL. The MIC was 
defined as the lowest concentration of a honey 
that produced no visible bacterial growth in the 
test tube when compared with the control. Mi-
nimal bactericidal concentration (MBC) was de-
termined by transferring the broths used for MIC 
determination on the MHA. The broth with the 
lowest concentration of the tested honey that did 
not produce growth of the tested organism was 
considered MBC. Meropenem (Sigma, St Lou-
is, MO, USA) was used as a positive control for 
growth inhibition when gram negative bacteria 
were used in the experiments, and vancomycin 
(Sigma, St Louis, MO, USA) when gram posi-
tive bacteria were used. The final antibiotic con-
centrations used in the assays as a control ran-
ged between 0.00004 and 0.128 mg/mL for both 
antibiotics. For the interpretation of these results 
EUCAST recommendations were followed (13). 
Statistical analysis
The differences between the tested honey sam-
ples with a respect to MICs and MBCs were sta-
tistically tested using Kruskal-Wallis test. The 
p<0.05 level of significance was applied.
RESULTS
The results of the antibacterial activity assay, 
performed with selected HS showed significant 
differences in MIC and MBC values when re-
ference bacterial and antibiotic resistant strains 
were tested (Table 2 and 3). Analyzing MICs, 
the strongest antibacterial potential showed 
Fir honeydew honey 2 (MIC=0.11 g/mL), Fir 
honeydew honey 1 (MIC=0.12 g/mL) and Mint 
honey (MIC=0.13 g/mL) in a case of both refe-
rence and antibiotic resistant bacterial strains. 
On the contrary, the weakest overall antibacte-
rial activity was showed by Locust tree honey 
(MIC=0.28 g/mL), Rapeseed honey (MIC=0.32 
g/mL) and Spring pasture honey (MIC=0.40 g/
Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of bacterial strain ( g/mL)*
S. aureus
ATCC 25923
P. aeruginosa
ATCC 27853
E. coli
ATCC 25922
A. baumannii
ATCC BAA-1605
A. baumannii
ATCC 19606
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Honey samples
Sage honey 1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Sage honey 2 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2
Maple honeydew 0.05 0.05 0.2 0.4 0.4 >0.4 0.1 0.2 0.1 0.1
Fir honeydew 1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1
Fir honeydew 2 0.05 0.05 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1
Chestnut honey 0.1 0.1 0.2 0.4 0.2 >0.4 0.2 0.4 0.1 0.1
Locust tree honey 0.2 >0.4 0.4 >0.4 0.4 >0.4 0.2 0.4 0.2 0.4
Lime tree honey 0.2 0.2 0.4 0.4 0.4 >0.4 0.1 0.2 0.2 0.2
Indigo bush honey 0.05 0.2 0.2 0.2 0.4 0.4 0.1 0.1 0.1 0.1
Rapeseed honey 0.4 >0.4 0.4 0.4 0.4 >0.4 0.2 0.4 0.2 0.4
Maple honey 0.2 >0.4 0.2 0.4 0.2 >0.4 0.1 0.1 0.1 0.1
Mint honey 0.1 0.1 0.2 0.2 0.2 0.4 0.05 0.1 0.1 0.1
Spring pasture 
honey 0.4 >0.4 0.4 >0.4 0.4 >0.4 0.4 0.4 0.4 0.4
Autumn pasture 
honey 0.05 0.05 0.4 0.4 0.2 0.2 0.05 0.1 0.1 0.1
Drugs for positive control for growth inhibition
Vancomycin 0.000001 0.000001 NT NT NT NT NT NT NT NT
Meropenem NT NT 0.000000064 0.000000064 0.000000006 0.000000006 >0.000032 >0.000032 0.000000250.00000025
Table 2. Antibacterial activity of tested honey samples on referent bacterial strains
*MIC, concentration required for 99% bacteriostatic effect; MBC, concentration required for 99% of bacterial killing effect; NT, not tested
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mL). For S. aureus MIC values ranged from 0.05 
g/mL (Fir honeydew honey, Maple honeydew 
honey and Autumn pasture honey) to 0.4 g/mL 
(Rapeseed honey and Spring pasture honey), and 
this bacterium was the most susceptible to all te-
sted honey samples. From all gram negative bac-
teria, antibiotic sensitive strain of A. baumannii 
was the most sensitive strain with MIC values 
ranged from 0.1 g/mL to 0.4 g/mL. Suprisingly, 
multidrug resistant A. baumannii strain was also 
sensitive to all tested honey samples with MIC 
values ranged from 0.05 g/mL (Autumn pastu-
re honey and Mint honey) to 0.4 g/mL (Spring 
pasture honey). When comparing sensitivity to 
honey of antibiotic sensitive and resistant strains 
of tested bacterial species no statistically signifi-
cant differences have been proven.
Analyzing bactericidal concentration of honey 
samples to all tested bacteria strains, the best re-
sults showed Fir honeydew honey 2 (MBC=0.13 
g/mL), Fir honeydew honey 1 (MBC=0.14 g/
mL) and Sage honey 1 (MBC=0.16 g/mL). The-
re were no significant differences in sensitivity 
to tested honey samples among antibiotic resi-
stant and sensitive bacterial strains. Again, the 
highest MBCs were determined for Rapeseed 
honey (MBC=0.56 g/mL), Locust tree honey 
(MBC=0.64 g/mL) and Spring pasture honey 
(MBC=0.64 g/mL) regarding the bacterial sensi-
tivity to antibiotic. S. aureus and A. baumannii 
regardless of sensitivity to antibiotics, were 
the most sensitive to all HSs, especially to Fir 
honeydew and Mint honey with MICs ranging 
from 0.05 g/mL – 0.1 g/mL, and MBCs ranging 
from 0.05 g/mL – 0.1 g/mL, respectively. 
DISCUSSION
There are several studies in which dark honey 
from the conifer forests of the mountainous regi-
ons of central Europe has been found to have par-
ticularly high antimicrobial activity (8,9,14,15). 
This honey is not from the nectar source, but 
from honeydew, produced by aphids sucking the 
sop from the leaves of the trees (14,15). This co-
incides with our results which showed that two 
samples of honeydew (Fir honeydew 1 and Fir 
honeydew 2) possess the best antibacterial acti-
vity according to the MIC as well as MBC va-
lues shown. Antibiotic resistant pathogens like 
MRSA, Pseudomonas aeruginosa, Klebsiella 
pneumoniae and Enterococcus faecalis are major 
causes of severe infections in hospitalized pati-
ents leading to longer hospital stays and higher 
mortality rates worldwide (2).
A good example of antibiotic resistant bacterium 
is A. baumannii, which is an opportunistic pat-
hogen that usually infects immunocompromised 
individuals through open wounds, catheters and 
Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of bacterial strain ( g/mL)*
MRSA P. aeruginosa E. coli A. baumanii 771 A. baumanii 53154
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
Honey samples
Sage honey 1 0.1 0.1 0.2 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Sage honey 2 0.1 0.1 0.2 0.4 0.2 0.2 0.2 0.2 0.2 0.2
Maple honeydew 0.05 0.05 0.2 0.4 0.4 >0.4 0.1 0.2 0.1 0.1
Fir honeydew 1 0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1
Fir honeydew 2 0.05 0.05 0.1 0.2 0.2 0.2 0.1 0.1 0.1 0.1
Chestnut honey 0.1 0.1 0.2 0.4 0.2 >0.4 0.2 0.4 0.1 0.1
Locust tree honey 0.2 >0.4 0.4 >0.4 0.4 >0.4 0.2 0.4 0.2 0.4
Lime tree honey 0.2 0.2 0.4 0.4 0.4 >0.4 0.1 0.2 0.2 0.2
Indigo bush honey 0.05 0.2 0.2 0.2 0.4 0.4 0.1 0.1 0.1 0.1
Rapeseed honey 0.4 >0.4 0.4 0.4 0.4 >0.4 0.2 0.4 0.2 0.4
Maple honey 0.2 >0.4 0.2 0.4 0.2 >0.4 0.1 0.1 0.1 0.1
Mint honey 0.1 0.1 0.2 0.2 0.2 0.4 0.05 0.1 0.1 0.1
Spring pasture 
honey 0.4 >0.4 0.4 >0.4 0.4 >0.4 0.4 0.4 0.4 0.4
Autumn pasture 
honey 0.05 0.05 0.4 0.4 0.2 0.2 0.05 0.1 0.1 0.1
Drugs for positive control for growth inhibition
Vancomycin 0.000001 0.000001 NT NT NT NT NT NT NT NT
Meropenem NT NT >0.000032 >0.000032 0.000000006 0.000000006 >0.000032 >0.000032 0.00000025 0.00000025
Table 3. Antibacterial activity of tested honey samples on antibiotic resistant bacterial strains
*MIC, concentration required for 99% bacteriostatic effect; MBC, concentration required for 99% of bacterial killing effect; NT, not tested
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breathing tubes (16). It is well documented that 
A. baumannii rapidly develops resistance to anti-
biotics and it is a real challenge to treat infections 
caused by this bacterium. Our results showed that 
A. baumannii as well as S. aureus were the most 
sensitive to honey, especially to Fir honeydew 
honey and Mint honey. These results suggest that 
they might be used in treating bacterial infecti-
ons, especially those caused with S. aureus and 
A. baumannii. This is in line with the report of 
other authors who found that honey was effective 
against antibiotic-resistant bacteria that colonize 
burn wounds, such as MRSA, vancomycin-resi-
stant Enterococcus spp. (VRE) and multiple-re-
sistant Gram-negative rods, including P. aeru-
ginosa, Acinetobacter spp. and members of the 
Enterobacteriaceae family (17-20). Furthermore, 
recent reviews on the successful usage of honey 
as a dressing on infected wounds show that many 
authors support the use of honey when treating 
infected wounds and some suggest even the 
prophylactic use of honey on the wounds of pa-
tients susceptible to MRSA and other antibiotic-
resistant bacteria (21-23).
Large variations in antimicrobial activity exist 
among honey collected from different envi-
ronments, which is possibly related to spatial 
and temporal variations in sources of nectar 
(10,24,25). Other reasons behind the recognition 
of honey as an effective antimicrobial agent are 
the use of non-standardized laboratory methods 
for testing. While antibiotic susceptibility testing 
uses standardized methods like EUCAST Re-
commendations, for antibacterial testing of natu-
ral products there are no such recommendations 
(13). It is very difficult to compare the results of 
different scientific studies and the results are very 
often confusing. Most commonly used in the re-
search are the diffusion method (agar well or disk 
diffusion methods) and the antimicrobial activity 
of honey is measured by a size of the inhibiti-
on zone. However, it was found that a disc im-
pregnated with various concentrations of honey 
added to an agar plate became dry because of va-
porization of fluid from the disc when the media 
were incubated at 37 °C for 24 hours. Also, honey 
is a mixture of different molecules that will not 
equally well diffuse through the agar and the re-
sults will not be precise. Therefore, we consider 
that assessment of the inhibitory and bactericidal 
concentration is a much better choice of testing 
because honey will easily come into contact with 
bacteria in the liquid media and such a complex 
mixture of compounds will better demonstrate its 
effect. By using this method, it was easy to find 
the MIC and MBC of tested honey that inhibited 
the growth of pathogens.
In our study, the weakest antibacterial potential 
was obtained by Locust tree honey, Rapeseed 
honey and Spring pasture honey. For these honey 
samples, we can assume that they do not have 
the necessary ingredients or synergy among ac-
tive components that would affect the bacteria. 
Namely, antibacterial activity of honey is qu-
ite a complicated issue due to the involvement 
of multiple ingredients, and large differences in 
their concentrations between the different types 
of honey. Closer determination of antibacterial 
compounds and their activities, and their involve-
ment in the antibacterial activity of honey could 
enable the standardization and help removing the 
main obstacles for the application of honey in the 
therapy of infections.
In conclusion, some honey of Croatian origin, 
like Fir honeydew and Mint honey, could be po-
tentially applied as an antibacterial agent in me-
dicine. We also demonstrated that locally produ-
ced honey possess excellent antibacterial activity 
comparable to the commercial honey. Our work 
shows that discovery and research of the anti-
microbial potential of different honey samples 
are of great importance and may contribute to the 
fight against bacterial resistance.
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